Cargando…

AI ENHANCED ECG ENABLED RAPID NON-INVASIVE EXCLUSION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) INFECTION

Detalles Bibliográficos
Autores principales:	Attia, Zachi Itzhak, Kapa, Suraj, Dugan, Jennifer, Pereira, Naveen, Noseworthy, Peter, Lopez-Jimenez, Francisco, Carter, Rickey, Cruz, Jessica, DeSimone, Daniel, Signorino, John, Halamka, John, Friedman, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091410/ http://dx.doi.org/10.1016/S0735-1097(21)04525-3

Ejemplares similares

Artificial Intelligence ECG to Detect Left Ventricular Dysfunction in COVID-19: A Case Series
por: Attia, Zachi I., et al.
Publicado: (2020)

Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs
por: Attia, Zachi I., et al.
Publicado: (2019)

An artificial intelligence–enabled ECG algorithm for comprehensive ECG interpretation: Can it pass the ‘Turing test’?
por: Kashou, Anthony H., et al.
Publicado: (2021)

Vascular Aging Detected by Peripheral Endothelial Dysfunction Is Associated With ECG‐Derived Physiological Aging
por: Toya, Takumi, et al.
Publicado: (2021)

Automated detection of low ejection fraction from a one-lead electrocardiogram: application of an AI algorithm to an electrocardiogram-enabled Digital Stethoscope( )
por: Attia, Zachi I, et al.
Publicado: (2022)

Artificial intelligence—electrocardiography to detect atrial fibrillation: trend of probability before and after the first episode
por: Christopoulos, Georgios, et al.
Publicado: (2022)

OSBORNE WAVE IN ECG AS A PREDICTOR OF HOSPITAL MORTALITY IN COVID-19 ASSOCIATED PNEUMONIA
por: Zagidullin, Naufal, et al.
Publicado: (2021)

Real-world performance, long-term efficacy, and absence of bias in the artificial intelligence enhanced electrocardiogram to detect left ventricular systolic dysfunction
por: Harmon, David M, et al.
Publicado: (2022)

PATIENT-SPECIFIC COVID-19 RESOURCE UTILIZATION PREDICTION USING FUSION AI MODEL
por: Tariq, Amara, et al.
Publicado: (2021)

AI to the rescue of voltage imaging
por: Lecoq, Jérôme A., et al.
Publicado: (2023)

Noninvasive assessment of dofetilide plasma concentration using a deep learning (neural network) analysis of the surface electrocardiogram: A proof of concept study
por: Attia, Zachi I., et al.
Publicado: (2018)

Usefulness of the synthesized 18‐lead ECG in premature ventricular contractions from near the HIS bundle
por: Matsumoto, Hirofumi, et al.
Publicado: (2023)

Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram
por: Attia, Zachi I., et al.
Publicado: (2021)

GABA in, garbage out: AIS-located proteasomes regulate the developmental GABA switch
por: Leterrier, Christophe
Publicado: (2020)

External validation of a deep learning electrocardiogram algorithm to detect ventricular dysfunction
por: Attia, Itzhak Zachi, et al.
Publicado: (2021)

Contact Tracing to Manage COVID-19 Spread—Balancing Personal Privacy and Public Health
por: Kapa, Suraj, et al.
Publicado: (2020)

Function through absence: Active RNA exclusion from chromosomes leads to proper cell division
por: Teves, Sheila S.
Publicado: (2020)

SARS-COV-2 PLATELET FUNCTION & THROMBOTIC COMPLICATIONS: EFFECTS OF ASPIRIN THERAPY IN COVID-19
por: Bhandari, Rohan, et al.
Publicado: (2021)

THE CARDIONERDS CASE REPORT SERIES: CONNECTING THE CARDIOLOGY COMMUNITY DURING THE COVID-19 PANDEMIC
por: Desai, Karan, et al.
Publicado: (2021)

H2C2 (HOME HOSPITAL AND CRITICAL CARE) - A 2.5 YEAR EXPERIENCE USING A NEW MODEL OF HOSPITAL AT HOME: DEVELOPMENT AND IMPLEMENTATION
por: Shen, Michael Y., et al.
Publicado: (2022)

CARDIOMYOPATHIC GENE MUTATIONS ALTER ACE2 EXPRESSION AND INFECTIVITY OF SARS-COV-2 IN HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
por: Kontorovich, Amy, et al.
Publicado: (2021)

SARS-COV-2 AND STROKE IN A LARGE HEALTHCARE SYSTEM
por: Katapadi, Aashish, et al.
Publicado: (2021)

DIFFERENTIAL MORTALITY AMONG HEART FAILURE PATIENTS DURING FIRST AND SECOND COVID19 SURGES IN NEW YORK
por: Mathai, Sheetal Vasundara, et al.
Publicado: (2022)

STATIN USE AND OUTCOMES IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION
por: Siddiqi, Hasan, et al.
Publicado: (2021)

LUNG INJURY AND FUNCTIONAL CAPACITY POST-SARS-COV-2 INFECTION
por: Bandera, Francesco, et al.
Publicado: (2021)

CARDIOVASCULAR PATIENT OUTCOMES AND COMPLICATIONS AFTER SARS-COV-2 INFECTION
por: Khodaverdi, M., et al.
Publicado: (2022)

ONLINE AND SIMULATION BASED CARDIAC POINT OF CARE ULTRASOUND TRAINING FOR RESIDENTS, A RANDOMIZED PILOT STUDY
por: Almonte, Matthew, et al.
Publicado: (2022)

CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION AND HISTORY OF CANCER
por: Siddiqi, Hasan, et al.
Publicado: (2021)

APABETALONE (RVX-208) REDUCES ACE2 PROTEIN ABUNDANCE AND PREVENTS SARS-COV-2 SPIKE PROTEIN BINDING TO HUMAN LUNG CELLS, A MOA THAT COULD ATTENUATE VIRAL ENTRY
por: Fu, Li, et al.
Publicado: (2021)

SARS-COV-2 VIRAL LOAD AND CARDIAC INJURY ARE INDEPENDENT AND INCREMENTAL PREDICTORS OF IN-HOSPITAL MORTALITY
por: Chehab, Omar, et al.
Publicado: (2021)

CARDIORESPIRATORY INDICES IN RELATION TO MARKERS OF PSYCHOPATHOLOGY AND NEUROCOGNITIVE FUNCTION IN POST SARS-COV-2 INFECTED SUBJECTS
por: Fragoulis, Christos, et al.
Publicado: (2022)

THE CLINICAL COURSE OF PATIENTS WITH A HISTORY OF ACUTE PERICARDITIS FOLLOWING VACCINATION AGAINST SARS-COV2
por: Wasserstrum, Yishay, et al.
Publicado: (2022)

RELATIONSHIPS BETWEEN MYOCARDIAL INJURY, INDEX HOSPITALIZATION CHARACTERISTICS, AND LONGER-TERM OUTCOMES IN SARS-COV-2 INFECTION
por: Weber, Brittany, et al.
Publicado: (2021)

SPORTS CLEARANCE FOLLOWING SARS-COV-2 INFECTION IN CHILDREN: DOES NONINVASIVE TESTING PREDICT ABNORMAL CARDIAC MRI?
por: Tejtel, Sara Kristen Sexson, et al.
Publicado: (2021)

HEALTH DISPARITIES INVOLVING HOSPITALIZATIONS AMONG COVID-19 VACCINATED CARDIOVASCULAR DISEASE PATIENTS INFECTED BY SARS-COV-2
por: Khodaverdi, M., et al.
Publicado: (2022)

ROLE OF ANTIBODIES, INFLAMMATORY MARKERS, AND ECHOCARDIOGRAPHIC FINDINGS IN POST-ACUTE CARDIOPULMONARY SYMPTOMS AFTER SARS-COV-2 INFECTION
por: Durstenfeld, Matthew, et al.
Publicado: (2022)

THE OCCURRENCE AND MORTALITY ASSOCIATED WITH MYOCARDIAL ISCHEMIA AND INJURY IN SARS-COV-2 INDUCED SEPSIS: A RETROSPECTIVE MULTICENTER OBSERVATIONAL ANALYSIS
por: Solsi, Anup, et al.
Publicado: (2022)

FEASIBILITY AND SAFETY OF A CARDIAC MAGNETIC RESONANCE IMAGING PROTOCOL INCLUDING PHARMACOLOGIC STRESS IN CHILDREN AFTER SARS-COV-2 INFECTION
por: Britt, Jolie, et al.
Publicado: (2021)

FOLLOW-UP OF HOSPITALIZED COVID-19 SURVIVORS: ASSESSMENT OF SHORT AND LONG-TERM CARDIOVASCULAR SEQUELAE AFTER SARS-COV-2 INFECTION
por: Birtolo, Lucia Ilaria, et al.
Publicado: (2022)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8vt5jpb1ee3mvr7vfahd23b0g9